protein (the 'protein-only' hypothesis), and suggested several possible mechanisms by which such an entity could self-replicate.
In the early 1980s, a single protein was identified as the major component both of the scrapieassociated fibrils in diseased brain and of brain preparations enriched in scrapie infectivity. Surprisingly, the amino-acid sequence of this diseaseassociated protein seems to be identical to that of a normal cellular protein. Also in the early 1980s, Stanley Prusiner coined the name 'prion' (protein infectious virion) to reflect his belief that the diseaseassociated protein -designated the prion protein scrapie-associated form, or PrP Sc -was the one to which Griffith's hypothesis referred. The normal cellular form of the protein is designated PrP C .
The idea that a disease-associated protein can in some way recruit a normal cellular protein to become disease-causing is contrary to much of conventional thinking about disease-causing agents; the idea has yet to be universally accepted, not least because a number of aspects of the transmission of related spongiform encephalopathies remain to be understood (see box). For example, it seems that both BSE and scrapie can be transmitted to other
The pressing public health issues concerning prions involve disease transmission, especially the possibility that BSE is transmitted from cattle to humans; there is some evidence that eating BSEinfected beef might be responsible for the emergence of a new strain of Creutzfeldt-Jakob disease in humans. Some critical questions about prion transmission, and speculations on the answers, are as follows.
How are prion diseases transmitted from one individual to another?
It is not at all clear how, for example, scrapie is passed from one sheep to another. There are examples of spongiform encephalopathies that seem to be passed on by eating infectious tissue -for example, BSE in cattle is thought to result from their being fed infectious material, and kuru, a human disease, is thought to be passed on by cannibalistic ritual. In addition, there is some evidence that scrapie can be passed on to animals by others in their herd or group, and perhaps even by contact with the same food or bedding material as infected animals.
How did the original PrP Sc arise, and is it possible to contract a prion disease without being infected or inheriting a mutant form of PrP? It is possible that there is a very low spontaneous rate of conversion from the normal cellular form to the 'scrapie' form of the protein. If the disease-associated form is capable of self-replication (see text and Fig. 1 ), a small amount of 'seed' would be necessary for conversion of PrP C to PrP Sc .
And if the disease-associated form is infectious, once it has replicated in one individual it might be able to pass to another. In addition, very rare mutations might convert the normal prion protein to a disease-associated form that aggregates or is transmitted more readily.
Can mutations in the PrP gene cause inherited diseases?
There are inherited spongiform encephalopathies that may be attributable to mutant forms of the PrP protein. How this causes disease is not yet clear.
If the infectious agent is an ordered polymer of PrP Sc , how can it get into the brain, across the blood-brain barrier?
This remains a mystery, but several lines of evidence suggest that the lymph nodes provide a way-station en route to the brain. Perhaps the agent is taken up by nerve terminals and travels retrogradely up to the central nervous system.
How can we test the likelihood of bovine-human transmission?
Studies with laboratory animals, such as mice and hamsters, have already provided a lot of information on the behaviour of PrP. Perhaps similar studies using rodents as well as primates will, together with increasing amounts of epidemiological evidence, provide new insights.
Can the PrP C -PrP Sc conversion be inhibited?
A number of strategies based on perturbing the presumed folding intermediates are being actively investigated.
How are prion protein diseases transmitted?
animals, such as mice or hamsters, but the transmitted disease retains some characteristics of either BSE or scrapie in the recipient animal. How is this possible if both diseases rely on the same single cellular protein for their perpetuation? Even 'strainspecific' characteristics of a single disease, such as how long it takes to develop and precisely which parts of the brain it affects, are transmitted with the infectious agent. Again, it is hard to see how a single protein can achieve this.
In this article, we will consider a model for the behavior of the normal and disease-associated prion proteins, and the extent to which this model explains what we know about transmissible spongiform encephalopathies. We will refer to the infectious entity as 'the agent' rather than the prion, in order to avoid confusing it with PrP Sc , as the protein-only hypothesis has yet to be proven definitively, for example by a demonstration that PrP Sc produced in vitro is infectious.
Infection by a protein-only agent
The normal, cellular form of the prion protein is not infectious. It is expressed in many tissues and by many cell types but has no known function. Mice lacking the PrP gene, first produced by Charles Weissmann and colleagues, are viable, but have altered neuronal function and develop neurological abnormalities later in life. Strikingly, these 'PrP knockout' mice are resistant to infection by the scrapie agent.
The failure to detect covalent chemical differences between the scrapie-associated PrP Sc and the normal PrP C led James Hope to suggest that they might be conformational isomers of one another, an idea originally postulated by Griffith and recently supported by spectroscopic studies. According to the protein-only hypothesis, infectious PrP Sc in an innoculum must be able to convert host PrP C into additional copies of PrP Sc , thus replicating itself. We and our colleagues have demonstrated that this conversion can take place outside the cell, in a system containing only PrP Sc isolated from infected brain and PrP C produced in cell culture. The conversion in vitro is most effective when the PrP C and PrP Sc used in the The normal function of PrP C , which is anchored to the cell surface by a glycosyl-phosphatidyl inositol (GPI) tail, is unclear, but might involve controlled two-dimensional oligomerization in the plane of the membrane. The functional form of PrP C may be a monomer, but could also be a dimer (as shown), or a higher oligomer. The oligomeric forms could be stabilized and prevented from proceeding to a PrP Sc nucleus by attachment to the membrane and/or specific interactions with another cell-surface molecule. Nucleation of PrP Sc would not occur in a cellular compartment either, provided that the PrP C concentration was kept below the 'critical concentration'. (b) In scrapie, PrP Sc replication could be initiated by an interaction between an extracellular PrP Sc seed with any form of cellsurface PrP C (the dimer is shown). This interaction could inhibit the normal function of PrP C and seed its ordered polymerization, producing more PrP Sc at the cell surface (provided that the inhibitory factors postulated in (a) could be circumvented), or, after internalization, in a cellular compartment (provided that the concentration of PrP C in the compartment exceeded the thermodynamic solubility of PrP Sc ). Accumulation of PrP Sc could block normal degradative and/or recycling pathways and lead to progressive neuronal dysfunction.
assay are derived from the same species, and it can propagate the biochemical properties associated with specific disease strains. These results suggest that other endogenous factors are not required for the conversion to occur, although such factors may normally be involved in vivo.
The conversion of PrP C to PrP Sc in vitro could take place by means of nucleated polymerization, with PrP Sc acting as a seed which induces polymerization of PrP C , or via the formation of a heterodimer containing one monomer of Prp Sc and one of PrP C . Mechanistic studies of the conversion in vitro strongly support the nucleated polymerization model; we believe that PrP Sc is a polymeric seed which replicates itself by inducing PrP C to polymerize in vivo and produce additional PrP Sc , as outlined in Figure 1 . For the purposes of the discussion below, we define a polymer to be a heterogeneous collection of multimers, each capable of growth. In contrast, an oligomer is a defined multimeric species which is not capable of further polymerization.
Neurodegeneration
Mice lacking the PrP gene can develop progressive coordination problems (as do scrapie-infected sheep and BSE-infected cattle). Thus, PrP Sc -induced neurodegeneration may be partly due to loss of normal PrP C function (the effect might be indirect, for example, if PrP C affects neural development in a manner which becomes evident only in aged animals). Neurodegeneration in infectious scrapie is clearly more rapid than that observed in the PrP knockout mice, however, arguing that PrP Sc itself is neurotoxic.
Adriano Aguzzi and Charles Weissmann have examined the roles of PrP Sc and PrP C in neuronal degeneration by grafting brain tissue from transgenic mice which overexpress PrP C (5-8-fold higher levels than in wild-type mice) into the brain of an otherwise identical mouse lacking the PrP gene. After inoculation with PrP Sc , the graft underwent rapid spongiform degeneration but no degeneration of the adjacent tissue lacking PrP C was observed, despite the fact that this tissue contained an amount of PrP Sc easily sufficient to transmit the disease. This result suggests that both cell-surface PrP C and extracellular PrP Sc are required for neurodegeneration to occur; PrP Sc may be a pathogenic ligand for PrP C (see Fig. 1 ). This model does not explain why degeneration is apparently specific to the brain even though PrP C expression is widespread. The answer to this question may involve the role played by PrP C in the unique biology of the neuron.
Function of the cellular prion protein
The function of the cellular prion protein PrP C , which is anchored to the cell-surface by a glycolipid attachment, is unknown. Its sequence is highly conserved, which usually implies that a protein has some important function. But the mild phenotype observed in some PrP knockout mice -reduced longterm potentiation of synaptic transmission, which is normally associated with learning, and sleep pattern abnormalities -suggests that whatever the normal role of PrP C , it can be at least partially fulfilled by other proteins.
Point mutations in the PrP gene can lead to inherited human neurological diseases which resemble transmissible scrapie, such as Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker disease and fatal familial insomnia. It is difficult to understand why a gene sequence that is only a single mutation away from protein aggregation and neurological disaster should be conserved. We propose a solution to this paradox. The normal function of PrP C may require its controlled oligomerization under conditions which prevent the uncontrolled polymerization that would lead to PrP Sc formation. The oligomerized normal protein could be involved in cell-cell interactions, synapse formation or membrane protein recycling. The elucidation of this normal function could hold the key to understanding the pathogenesis of scrapie and related spongiform encephalopathies.
